The expression of the a3 and a5 chains was already noticeably reduced in adenomas, and was completely absent in most colonic carcinomas. In contrast, a6, P3I, and 4 expression was maintained in adenomas, whereas the transformation from benign to malignant neoplasms associated with infiltrative growth was characterised by diminished or lost expression of a6, 1I, and 1 chains. Thus, the decreased expression of integrins in human colon carcinomas may contribute to the altered adhesion and migration properties of these tumour cells.
Cancer of the large bowel, the second most common site for carcinomas in both men and women, accounts for about 20% of all deaths from malignant disease in western Europe. Unfortunately, the death rate for this disease has not changed significantly for the past 40 years. ' The propensity of malignant tumour cells to spread from their site of origin to other parts of the body is one of the principal reasons for the high rate of cancer mortality. If oncologists were able to treat metastatic disease or prevent the formation of metastases, the incidence of death would be substantially reduced. The ability of tumour cells to adhere to basement membranes is known to play a crucial role in the complex process of metastasis formation,) and tumour cell adhesion to basement membranes has been shown to correlate with their ability to metastasise. 3 The interaction of tumour cells and the extracellular matrix is mainly mediated through binding of extracellular matrix components to specific tumour cell surface adhesion receptors.
Integrins are transmembrane protein complexes consisting of non-covalently associated a and 13 subunits. 4 They mediate both cell-substratum and cell-cell adhesion.' As originally described,6 integrins were divided into three subfamilies, each with a common 13 subunit capable of associating with a specific group of a subunits. More recent works have shown that there are at least 11 different a subunits and eight 13 subunits, and that certain a subunits can combine with more than one 13 subunit. Our results indicate a sequence of alterations in integrin expression during the transformation of normal colonic mucosa via adenomas into colorectal carcinomas. Firstly, the transformation to adenomas was characterised by a diminished expression of a3, and a5 chains of the VLA complexes (Fig 2) , and secondly, the transformation from adenomas to carcinomas was characterised by a diminished expression of a6 chain (Fig 1) . These changes could be the result to a series of genetic events which have been recently described in colorectal cancer.30
An activation of ras oncogenes is observed at an early stage in the course of the adenomacarcinoma sequence in the human intestine. Approximately 50% of adenomas larger thanwhereas the CtAiI expression was retained by the transformed cells. 3 The second most common region of genetic alteration in colorectal tumours is in chromosome 18q, which is changed in more than 70% of carcinomas. Using the polymerase chain reaction in an exon connection strategy, Fearon et al identified the altered sequence mapping as 18q. 33 This gene, termed the DCC gene (deleted in colorectal carcinomas), encodes a protein with significant homologies to members of the family of cell adhesion molecules.34 Therefore, the DCC gene might play a role in the development of colorectal tumours, perhaps through changes in physiological cell-cell and cell-matrix interactions. However, this speculation as well as the relation between the genetic changes and the diminished expression of integrins in human colorectal adenomas and cancers remain to be investigated. 
